CSIR-NIIST Develops Technology To Convert Biomedical Waste Into Soil Additives

THIRUVANANTHAPURAM: CSIR-National Institute for Interdisciplinary Science and Technology (NIIST) in Thiruvananthapuram has developed a technology that converts pathogenic biomedical waste into value-added soil additives that eliminate the need for costly and energy-intensive incineration.

The rig will be installed and commissioned at a function at AIIMS, New Delhi on Monday. The rig ensures the safe disposal of waste materials such as blood, urine, sputum and laboratory disposables while simultaneously imparting a pleasant fragrance to the treated material.

The prototype has a daily processing capacity of 400 kg, with an initial capacity to handle 10 kg of degradable medical waste per day. Once validated and approved by competent authorities, the technology will be ready for full-scale implementation in healthcare facilities across the country.

India generates approximately 743 tonnes of biomedical waste daily, according to the 2023 annual report of the Central Pollution Control Board (CPCB). Traditional disposal methods, including incineration and open dumping, pose serious health and environmental risks, including the release of carcinogenic pollutants, particulate matter and ash residues.

SOURCE : The Indian Express

Related Posts

  • Pharma
  • July 24, 2025
  • 185 views
Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…

  • Pharma
  • July 22, 2025
  • 270 views
DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

The Directorate General of Foreign Trade ( DGFT ) has notified an extension in the deadline for submitting applications for the export of Pharma Grade Sugar. This was communicated through Trade Notice…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra